News
Human implants can remain inside the body for years, and in some applications they are expected to function for decades. For metallic implant components, corrosion resistance is therefore not simply a surface-quality requirement. It is closely connected with material stability, mechanical performance, wear behavior, manufacturing consistency, and long-term implant reliability.
This makes material and process selection especially important when sourcing human implant castings, including cast components used for orthopedic and other surgical implant applications.
A casting that looks acceptable externally may still contain porosity, inclusions, surface contamination, microstructural inconsistencies, or machining defects that influence its corrosion behavior later. Buyers should therefore evaluate implant castings as an integrated system involving:
Alloy selection
Investment casting process control
Chemical composition
Microstructure
Casting integrity
Surface condition
Machining quality
Cleaning and finishing
Corrosion testing
Material traceability
This guide explains the main factors buyers and engineers should consider when selecting corrosion-resistant implant castings.
Metallic implants operate in a much more complex environment than ordinary industrial castings.
After implantation, metallic components may be exposed to physiological fluids containing water, salts, proteins, and other biological substances. At the same time, an implant may experience repeated mechanical loading, friction, micromotion, and contact with other components.
Corrosion behavior therefore depends not only on the alloy itself but also on the finished device design, surface condition, manufacturing process, and intended anatomical use.
The FDA notes that medical-device material evaluation considers the material's properties together with the device's intended use and function. Biocompatibility assessment also takes manufacturing processes, anatomical location, and duration of exposure into account.
For casting buyers, this means that asking only:
“Is this alloy corrosion resistant?”
is not enough.
A better question is:
“Can the supplier consistently manufacture this alloy into implant castings with the required chemistry, microstructure, surface quality, internal integrity, and traceability?”
Material selection should be the first step when developing a corrosion-resistant cast implant component.
One of the most established casting materials for surgical implant applications is cobalt-chromium-molybdenum alloy (CoCrMo).
ASTM F75-23 specifically covers cobalt-28 chromium-6 molybdenum alloy unfinished investment castings and casting alloy for surgical implant applications. The standard includes chemical, mechanical, and metallurgical requirements.
ISO 5832-4:2024 likewise specifies characteristics and corresponding test methods for cobalt-chromium-molybdenum casting alloy used in the manufacture of surgical implants.
For buyers sourcing implant-grade castings, therefore, material requirements should be stated through a recognized specification rather than simply requesting:
“medical cobalt alloy”
or
“corrosion-resistant stainless steel.”
The exact alloy grade and applicable specification should appear on the engineering drawing, purchase specification, or quality agreement.
CoCrMo alloys are attractive for certain implant applications because they combine several properties important to long-term implant components:
Corrosion resistance
High mechanical strength
Wear resistance
Hardness
Ability to maintain performance under repeated loading
Suitability for precision investment casting
Chromium contributes significantly to corrosion resistance through the formation of a protective passive oxide layer on the metal surface.
However, using the correct alloy grade alone does not guarantee corrosion resistance.
Casting defects, surface contamination, improper heat treatment, poor machining, or inappropriate contact with another metallic material can still influence the corrosion performance of the finished device.
Corrosion should not be treated as one single failure mechanism.
Different implant designs and service conditions can produce different corrosion risks.
Important mechanisms include:
| Corrosion Type | Typical Concern | What Buyers Should Review |
|---|---|---|
| Pitting corrosion | Localized attack at vulnerable surface areas | Alloy chemistry, inclusions, surface finish |
| Crevice corrosion | Corrosion inside narrow gaps | Device geometry, interfaces, surface quality |
| Galvanic corrosion | Interaction between dissimilar metallic materials | Material combinations |
| Fretting corrosion | Micromotion between contacting surfaces | Joint design, surface finish, loading |
| Tribocorrosion | Combined wear and electrochemical degradation | Bearing/contact surfaces |
| General corrosion | Broad material degradation | Alloy selection and environment |
The FDA has specifically discussed galvanic and fretting corrosion in metallic implants. Galvanic corrosion can occur when dissimilar metals are electrically connected in the body, while fretting corrosion can be associated with micromotion at contacting interfaces.
For this reason, corrosion resistance must be evaluated at the device-system level, not only at the raw-material level.
Small changes in alloy chemistry can influence:
Corrosion behavior
Mechanical properties
Castability
Carbide formation
Microstructure
Heat-treatment response
Wear performance
For implant castings manufactured according to a defined standard such as ASTM F75, the supplier should control melting and verify chemical composition against the applicable specification.
Buyers should request appropriate material documentation and establish traceability between:
Raw material → melt/heat → casting lot → inspection results → delivered components
This becomes particularly important when castings will undergo subsequent machining, polishing, coating, assembly, or validation by another supplier.
Porosity is one of the most important manufacturing issues to control in precision implant castings.
Common types include:
Gas porosity
Shrinkage porosity
Micro-porosity
Localized internal cavities
Porosity can affect much more than appearance.
Depending on location and severity, it may influence:
Mechanical strength
Fatigue behavior
Machining results
Surface integrity
Dimensional stability
Corrosion performance
A subsurface pore may not initially be visible. After machining or polishing, however, it can become exposed at the finished surface.
This creates a potential local discontinuity where fluids or contaminants may collect.
Good process control typically involves:
Proper wax-pattern design
Suitable gating and feeding
Controlled shell preparation
Stable melting parameters
Controlled pouring temperature
Appropriate vacuum or atmospheric melting practices where required
Solidification control
Process validation
For complex implant geometries, casting simulation may also help identify regions susceptible to shrinkage before tooling and production are finalized.
Inclusions are another important concern in surgical implant castings.
Possible sources include:
Ceramic shell material
Oxides
Slag
Refractory particles
Contaminants introduced during melting or handling
An inclusion can create a local discontinuity in the casting.
For implant components subjected to repeated loading, buyers should therefore pay particular attention to melt cleanliness and inclusion control.
Controlled raw-material handling
Clean melting equipment
Appropriate furnace practices
Slag and oxide control
Stable ceramic-shell production
Controlled pouring procedures
Inspection of critical castings
ASTM F75-23 calls for several examinations of qualifying product castings, including liquid penetrant, radiographic, metallographic, and hardness examination.
This illustrates why implant casting procurement involves considerably more than a basic visual inspection.
Chemical composition tells only part of the story.
Two castings made from nominally the same alloy can perform differently if their microstructures differ significantly.
Microstructure can be affected by:
Cooling rate
Section thickness
Solidification conditions
Heat treatment
Alloy chemistry
Casting geometry
Areas with significantly different wall thicknesses can solidify at different rates, producing different microstructural conditions within the same component.
Microstructure can affect:
Strength
Ductility
Hardness
Fatigue resistance
Wear behavior
Corrosion response
For demanding implant castings, metallographic examination may therefore form part of material and process qualification.
Good corrosion performance begins before molten metal enters the mold.
A poorly designed casting can create manufacturing conditions that increase the risk of defects.
During design-for-manufacturing review, engineering teams should evaluate:
Wall thickness
Section transitions
Fillet radii
Internal corners
Gating locations
Feeding requirements
Machining allowance
Datum surfaces
Critical load-bearing sections
Large transitions between thick and thin areas can create uneven cooling and shrinkage.
Where possible, gradual transitions should be used.
Sharp corners can contribute to:
Stress concentration
Difficult mold filling
Uneven solidification
Finishing difficulties
Appropriate radii generally make precision casting more manageable.
Surfaces that will eventually become:
Articulating surfaces
Bone-contact surfaces
Taper interfaces
Screw interfaces
Polished areas
Coating areas
should be clearly identified during casting development.
The casting supplier can then design appropriate machining allowances and gating locations around them.
Corrosion resistance is strongly connected to the condition of the finished metal surface.
A theoretically corrosion-resistant alloy can behave differently when its surface contains:
Embedded contaminants
Grinding damage
Residual abrasive particles
Surface cracks
Casting defects
Rough machining marks
Foreign metallic contamination
Surface-processing controls therefore become an important part of implant manufacturing.
Depending on the finished component and validated manufacturing process, downstream operations may include:
Grinding
Machining
Polishing
Blasting
Cleaning
Passivation or other defined surface treatments
Specialized coatings
The appropriate sequence depends on the device design, alloy, regulatory requirements, and validated manufacturing process.
There is no universal rule that every implant surface should be as smooth as possible.
Different areas of an implant may require different surface characteristics.
For example, one component may contain:
Highly polished articulating surfaces
Controlled rough surfaces intended for fixation
Machined connection interfaces
Coated sections
Non-contact external surfaces
Therefore, procurement drawings should not simply state:
“Good surface finish required.”
Instead, critical surfaces should have defined and measurable requirements.
This allows the casting and machining supplier to determine the proper finishing route.
Many implant systems contain more than one component.
If different metallic materials are combined, galvanic interactions may need to be evaluated.
Galvanic corrosion occurs when dissimilar metals form an electrochemical couple in an electrolyte.
The FDA maintains recognition information for ASTM F3044, a test method addressing the potential for galvanic corrosion in medical implants.
This is especially relevant when a medical device includes:
Modular metallic components
Screws and plates
Metal junctions
Mixed alloy assemblies
Tapered connections
Therefore, buyers should evaluate the complete implant system rather than qualifying each casting independently.
Some implants experience repeated small movements between contacting components.
Examples can include modular interfaces and mechanically loaded connections.
Repeated micromotion may damage the protective passive surface film. Mechanical wear and electrochemical corrosion can then interact.
This phenomenon is commonly discussed as fretting corrosion or, more broadly, tribocorrosion.
Important design factors include:
Material combination
Contact pressure
Surface roughness
Mechanical loading
Relative motion
Interface geometry
A material that performs well in a static corrosion test may not behave identically under repeated mechanical contact.
Therefore, implant evaluation should reproduce relevant aspects of the intended operating environment whenever required by the device-development process.
A corrosion-resistant implant casting must also be structurally sound.
Inspection should therefore address both surface and internal defects.
Useful for identifying:
Surface discontinuities
Incomplete filling
Shell-related defects
Excessive surface irregularities
Grinding defects
Precision implant components may require tight control of:
Overall dimensions
Hole positions
Wall thickness
Datum locations
Machining allowance
Depending on complexity, inspection methods may include conventional gauges, fixtures, optical measurement, or coordinate measuring systems.
Liquid penetrant testing can reveal certain surface-breaking discontinuities.
It is particularly useful for detecting surface defects that may not be easily visible under normal inspection.
Radiography can help identify certain internal discontinuities, including:
Internal porosity
Shrinkage
Inclusions
Internal cavities
ASTM F75-23 includes liquid penetrant and radiographic examination requirements within its specification for CoCrMo surgical implant castings.
Metallography can help evaluate:
Microstructure
Carbide distribution
Casting structure
Metallurgical consistency
Depending on the applicable material specification, testing may address properties such as:
Tensile strength
Yield strength
Elongation
Hardness
The exact acceptance requirements should always be taken from the applicable product specification and current standard rather than assumed from general material data.
Traceability is one of the most important differences between ordinary commercial castings and cast components intended for regulated medical-device manufacturing.
A robust system should allow the manufacturer to connect a delivered component with relevant production records.
Depending on the quality system and contractual requirements, these records may cover:
Raw material
Heat or melt number
Wax production lot
Shell production
Casting batch
Heat treatment
Inspection records
Machining lot
Cleaning process
Final release documentation
For OEM customers, this helps support investigation, validation, and documentation throughout the medical-device supply chain.
Material contamination can undermine an otherwise carefully selected implant alloy.
Manufacturers should consider contamination risks during:
Grinding
Blasting
Cutting
Machining
Polishing
Handling
Cleaning
For example, shared tools or blasting media used across different alloys can potentially introduce foreign metallic particles.
A medical casting supplier should therefore have appropriate controls for material segregation and cleanliness according to the customer's validated manufacturing requirements.
Cleaning should not be treated as an afterthought.
Investment casting can involve several manufacturing materials, including:
Wax
Ceramic shell
Grinding media
Cutting fluids
Machining lubricants
Polishing compounds
Cleaning agents
Residual contaminants must be appropriately controlled before the component proceeds to downstream medical-device manufacturing.
The exact cleaning and acceptance requirements should be defined according to the finished device, process validation, and applicable regulatory requirements.
This distinction is extremely important.
ASTM F75 covers unfinished CoCrMo investment castings and casting alloy for surgical implant applications. It does not by itself certify that a completed device is safe or approved for implantation.
Likewise, choosing a material that complies with an implant-material standard does not eliminate the need to evaluate:
Finished device geometry
Manufacturing processes
Surface treatments
Cleaning
Biocompatibility
Mechanical performance
Corrosion behavior
Sterilization
Intended clinical use
The FDA evaluates implant materials in the context of the device and its intended use rather than treating raw-material selection alone as proof of safety.
For B2B sourcing, suppliers should therefore describe their capability accurately.
A responsible statement is:
“Castings can be manufactured to the specified implant-material standard and customer drawing requirements.”
It is not appropriate to assume that material compliance alone makes an unfinished casting a clinically approved implant.
Precision casting of an industrial pump component and casting of a surgical implant component may use similar fundamental processes, but the quality expectations are very different.
When evaluating a human implant casting manufacturer, buyers should investigate the supplier's ability to control:
Can the supplier source, identify, melt, and verify the specified implant-grade alloy?
Can tooling consistently reproduce complex shapes and critical dimensions?
Are wax injection, shell building, melting, pouring, and solidification parameters controlled?
Can chemical composition, microstructure, and heat treatment be managed consistently?
Does the supplier have appropriate dimensional and non-destructive inspection capabilities?
Can each production lot be linked to manufacturing and inspection records?
Can inspection certificates and required quality documents be provided with each order?
For medical OEM projects, process discipline is often more valuable than simply obtaining the lowest casting price.
Procurement teams can use the following questions when qualifying potential casting suppliers.
Which implant-grade alloys can you cast?
Can you manufacture according to ASTM F75 or the specified ISO material standard?
How is each melt identified and controlled?
How is chemical composition verified?
What investment casting process is used?
How are shrinkage and porosity controlled?
Can casting simulation be performed for complex components?
How are ceramic-shell defects controlled?
What NDT methods are available?
Can radiographic inspection be performed when required?
Is liquid penetrant inspection available?
Can metallographic inspection be provided?
What dimensional inspection equipment is available?
Can critical dimensions be documented?
How is tooling wear monitored?
Can machining and polishing be provided?
How is cross-contamination controlled?
Are dedicated finishing processes available where required?
Can finished parts be traced back to melt and production lot?
What production records are retained?
What documentation is supplied with each shipment?
These questions help separate general investment casting suppliers from manufacturers prepared to support demanding medical-device supply chains.
A detailed RFQ helps the casting manufacturer evaluate the project correctly before quoting.
Ideally, provide:
2D engineering drawing
3D CAD model
Required alloy
Applicable material standard
Finished component dimensions
Casting dimensions
Critical tolerances
Surface-finish requirements
Machining requirements
Heat-treatment requirements
NDT requirements
Metallographic requirements
Mechanical-property requirements
Cleaning requirements
Traceability requirements
Expected annual quantity
Prototype quantity
Packaging requirements
Where relevant, clearly distinguish between:
as-cast requirements, machined casting requirements, and finished-device requirements.
This reduces misunderstandings between the implant OEM, casting manufacturer, machining supplier, and downstream device manufacturer.
Substituting an alloy without engineering validation can create significant material and regulatory risks.
Correct chemistry does not guarantee acceptable microstructure, porosity, surface integrity, or mechanical performance.
A visually attractive casting can still contain internal shrinkage or inclusions.
Critical implant surfaces should be identified during casting and machining development rather than after tooling has been completed.
Material combinations can introduce galvanic-corrosion considerations.
Material compliance is only one part of finished medical-device validation.
For implant-related components, inability to trace manufacturing batches can become a serious supply-chain problem.
Selecting implant casting material involves trade-offs.
The strongest alloy is not automatically the most suitable material. Likewise, the most corrosion-resistant material in one laboratory condition is not necessarily the correct solution for every implant.
Engineering teams must balance:
Corrosion resistance
Wear resistance
Fatigue performance
Strength
Ductility
Castability
Machinability
Surface finishing
Component geometry
Material compatibility
Regulatory requirements
Intended clinical application
This is why early cooperation among implant designers, metallurgical engineers, casting suppliers, machining suppliers, and quality teams can significantly reduce development risk.
Cobalt-chromium-molybdenum is an established alloy family for certain surgical implant castings. ASTM F75-23 covers cobalt-28 chromium-6 molybdenum unfinished investment castings and casting alloy for surgical implant applications, while ISO 5832-4:2024 addresses cobalt-chromium-molybdenum casting alloy for surgical implants.
CoCrMo alloys provide a useful combination of corrosion resistance, mechanical performance, hardness, wear resistance, and investment-casting capability for appropriate implant applications.
Material selection must nevertheless be based on the requirements of the particular finished device.
Yes. Porosity can influence mechanical integrity and may become exposed during machining or polishing. Controlling both surface and internal casting defects is therefore important.
Surface condition can influence corrosion behavior, but polishing should be considered as part of a validated finished-device manufacturing process rather than treated as a universal solution. Different implant surfaces may also require different surface characteristics.
Requirements depend on the applicable specification and customer drawing. ASTM F75-23 includes chemical, mechanical, metallurgical, hardness, liquid penetrant, and radiographic requirements for the cast products within its scope.
No. ASTM F75 is a material and casting specification and does not by itself constitute regulatory approval of a completed implant. Finished devices require evaluation according to their intended use and applicable regulatory requirements.
Focus on the complete manufacturing process rather than alloy designation alone. Important areas include material specification, melt control, casting integrity, microstructure, surface condition, machining, cleaning, material compatibility, inspection, and traceability.
Choosing corrosion-resistant human implant castings requires much more than selecting a stainless or cobalt-based alloy from a material list.
For implant casting projects, corrosion resistance depends on the interaction between material chemistry, casting quality, microstructure, surface condition, device design, mechanical loading, material combinations, and downstream manufacturing processes.
For cast surgical implant components, cobalt-chromium-molybdenum alloys manufactured to appropriate specifications such as ASTM F75 or ISO 5832-4 are established options. However, compliance with a material specification is only the starting point.
B2B buyers should evaluate whether their casting supplier can consistently control:
Implant-grade materials
Investment casting parameters
Porosity and inclusions
Microstructure
Heat treatment
Critical dimensions
Surface integrity
Non-destructive testing
Cleaning
Production documentation
Full lot traceability
By defining these requirements early and working with a supplier experienced in precision medical investment casting, implant manufacturers can reduce development risks, improve production consistency, and build a stronger foundation for downstream device validation and long-term product reliability.
